Daewoong Co., Ltd.

Overview

Daewoong Co., Ltd. is a South Korean holding company that manages Daewoong Pharmaceutical and its subsidiaries, focusing on investments in the pharmaceutical and healthcare sectors. The company is headquartered in Seoul, South Korea, and operates globally with subsidiaries and branches in countries such as the United States, Japan, the Philippines, Thailand, India, Indonesia, and China. Daewoong Pharmaceutical, established in 1945, is a leading pharmaceutical company in Korea, specializing in the manufacture of pharmaceutical products, including prescription and over-the-counter healthcare products. The company has diversified its portfolio to include global healthcare, receiving U.S. FDA approval for some of its products, including Meropenem Inj. and Botulinum toxin Biosimilar. Daewoong Co., Ltd. primarily engages in investing, asset management, and related financial activities, focusing on private equity and venture capital investments in early-stage, growth, and late-stage companies. The company's geographical focus includes South Korea, the United States, Japan, the Philippines, Thailand, India, Indonesia, and China. Daewoong Co., Ltd. has a diverse portfolio of investee companies across various industries, including pharmaceuticals, biotechnology, medical devices, healthcare services, consumer health, diagnostics, contract manufacturing, research and development, regulatory affairs, clinical services, sourcing, business development, supply chain management, marketing, and sales. The company's investment philosophy emphasizes innovation, global collaboration, and the development of local pharmaceutical industries, contributing to the advancement of the global healthcare sector. Daewoong Co., Ltd. has a track record of successful investments and collaborations, reflecting its commitment to improving the quality of life worldwide through cutting-edge research and global partnerships. The company's strategic approach involves expanding its self-operated infrastructure, establishing collaborative networks with multiple partners, and directly managing key customers at the headquarters level to continuously strengthen its market dominance. By actively discovering and nurturing global talent, Daewoong Co., Ltd. contributes to the development of local pharmaceutical industries and advances as a healthcare company trusted worldwide.

Investment Focus

• Innovative pharmaceutical and healthcare companies
• Strong research and development capabilities
• Global market potential
• Commitment to improving quality of life through healthcare solutions
• Alignment with Daewoong's strategic focus areas

Portfolio Companies